Erik Oliemuller

469 total citations
11 papers, 339 citations indexed

About

Erik Oliemuller is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Erik Oliemuller has authored 11 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Erik Oliemuller's work include Cancer Cells and Metastasis (7 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Cancer Genomics and Diagnostics (2 papers). Erik Oliemuller is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Cancer Genomics and Diagnostics (2 papers). Erik Oliemuller collaborates with scholars based in United Kingdom, Spain and United States. Erik Oliemuller's co-authors include Beatrice A. Howard, Iskander Aurrekoetxea-Rodríguez, María dM Vivanco, Robert Kypta, So Young Lee, Giacomo Domenici, Ignacio Zabalza, Bruno M. Simões, Valentine Comaills and Miriam Rábano and has published in prestigious journals such as Oncogene, International Journal of Cancer and eLife.

In The Last Decade

Erik Oliemuller

11 papers receiving 338 citations

Peers

Erik Oliemuller

MB

ONCOL

CR

GENET

PRM

Alice Boulghourjian Australia

Pasquale Pellegrini Spain

Shi-Yuan Cheng United States

B Osborne United States

Mary Iconomou Australia

Martin Lukačišin United States

Suzana Gomes United States

Xu-Yu Yang United States

Lilian Lee Canada

S Ripka Germany

Alice Boulghourjian Australia

Erik Oliemuller

227 ×0.9

MB

142 ×0.9

ONCOL

154 ×1.3

CR

23 ×0.5

GENET

30 ×0.8

PRM

Citations per year, relative to Erik Oliemuller Erik Oliemuller (= 1×) peers Alice Boulghourjian

Countries citing papers authored by Erik Oliemuller

Since Specialization

Citations

This map shows the geographic impact of Erik Oliemuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Oliemuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Oliemuller more than expected).

Fields of papers citing papers by Erik Oliemuller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Oliemuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Oliemuller. The network helps show where Erik Oliemuller may publish in the future.

Co-authorship network of co-authors of Erik Oliemuller

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Oliemuller. A scholar is included among the top collaborators of Erik Oliemuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Oliemuller. Erik Oliemuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Oliemuller, Erik, Richard Newman, & Beatrice A. Howard. (2022). Intraductal Injections into the Mouse Mammary Gland. Methods in molecular biology. 2471. 221–233. 1 indexed citations

2.

Kim, Hyojin, et al.. (2021). Sox11 regulates mammary tumour-initiating and metastatic capacity in Brca1-deficient mouse mammary tumour cells. Disease Models & Mechanisms. 14(5). 2 indexed citations

3.

Oliemuller, Erik, Richard Newman, Shane Foo, et al.. (2020). SOX11 promotes epithelial/mesenchymal hybrid state and alters tropism of invasive breast cancer cells. eLife. 9. 24 indexed citations

4.

Oliemuller, Erik, et al.. (2020). Regulatory roles for SOX11 in development, stem cells and cancer. Seminars in Cancer Biology. 67(Pt 1). 3–11. 54 indexed citations

5.

Domenici, Giacomo, Iskander Aurrekoetxea-Rodríguez, Bruno M. Simões, et al.. (2019). A Sox2–Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells. Oncogene. 38(17). 3151–3169. 117 indexed citations

6.

Kogata, Naoko, et al.. (2018). Sox9 regulates cell state and activity of embryonic mouse mammary progenitor cells. Communications Biology. 1(1). 228–228. 11 indexed citations

7.

Oliemuller, Erik, Naoko Kogata, Philip Bland, et al.. (2017). SOX11 promotes invasive growth and ductal carcinoma in situ progression. The Journal of Pathology. 243(2). 193–207. 31 indexed citations

8.

Kogata, Naoko, et al.. (2014). Neuregulin-3 Regulates Epithelial Progenitor Cell Positioning and Specifies Mammary Phenotype. Stem Cells and Development. 23(22). 2758–2770. 10 indexed citations

9.

Zvelebil, Marketa, Erik Oliemuller, Qiong Gao, et al.. (2013). Embryonic mammary signature subsets are activated in Brca1 -/- and basal-like breast cancers. Breast Cancer Research. 15(2). R25–R25. 51 indexed citations

10.

Oliemuller, Erik, Rafael Peláez, Saray Garasa, et al.. (2012). Phosphorylated tubulin adaptor protein CRMP‐2 as prognostic marker and candidate therapeutic target for NSCLC. International Journal of Cancer. 132(9). 1986–1995. 31 indexed citations

11.

Fontán, Lorena, Erik Oliemuller, Juan J. Martínez‐Irujo, Carlos de Miguel, & Ana Rouzaut. (2006). All‐trans‐retinoic acid inhibits collapsin response mediator protein‐2 transcriptional activity during SH‐SY5Y neuroblastoma cell differentiation. FEBS Journal. 274(2). 498–511. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact